Gilead Sciences Inc (NASDAQ: GILD) won another exclusive deal for its Hepatitis C drug, when it signed with the Catamaran Corp. On Wednesday shares of Gilead Sciences Inc. (NASDAQ:GILD) closed at $98.43. Company’s sales growth for last 5 years was 16.00% and EPS growth for next 5 years is recorded as 33.42%.
Taylor Morrison Home Corporation (NYSE:TMHC) on 28 January announced that it closed the previously announced sale of Monarch Corporation, formerly its Canadian operations, to an affiliate of Mattamy Homes Limited (“Mattamy”). Taylor Morrison Home Corporation (NYSE:TMHC) in last trading activity moved up 0.93% to close at $18.47. Company weekly performance is 6.33% while its quarterly performance stands at 5.36%. Taylor Morrison Home Corporation (NYSE:TMHC) is -29.96% away from its 52 week high.
Under Armour Inc (NYSE:UA) announced financial results for the fourth quarter ended December 31, 2014 and beat expectations. Net revenues came in at $895 million, above estimates of $848.96 million and an increase of 31 percent compared to the prior year period. Net income was $88 million, an increase of 37 percent compared to the $64 million reported in the year-ago period. On last trading day Under Armour, Inc. (NYSE:UA) moved up 1.02% to close at $73.57. Its volatility for the week is 2.41% while volatility for the month is 2.66%. UA’s sales growth for past 5 years was 26.30% and its EPS growth for past 5 years was 31.60%. Under Armour, Inc. (NYSE:UA) monthly performance is 12.66%.
General Motors Company (NYSE:GM) has paid $93 million through its compensation program for those killed or injured as a result of defective ignition switches, according to a regulatory filing released Wednesday. General Motors Company (NYSE:GM) has 4.60% insider ownership while its institutional ownership stands at 70.30%. In last trading activity company’s stock closed at $35.83.
On last trading day Celsion Corp. (NASDAQ:CLSN) moved up 0.76% to close at $2.23. Its volatility for the week is 2.65% while volatility for the month is 3.63%. CLSN’s sales growth for past 5 years was -27.50% and its EPS growth for past 5 years was 28.90%. Celsion Corp. (NASDAQ:CLSN) monthly performance is -7.85%.